Active Immunization of Patients With Head and Neck Squamous Cell Carcinoma (HNSCC) Using Fibroblasts Transfected With DNA From Autologous Tumor
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 04 Feb 2016
At a glance
- Drugs IC 1002 (Primary)
- Indications Squamous cell cancer; Unspecified
- Focus Adverse reactions
- 14 Jan 2016 Planned primary completion date changed from 1 Jan 2017 to 1 Jul 2017, according to ClinicalTrials.gov record.
- 14 Jan 2016 Planned initiation date changed from 1 Oct 2014 to 1 Apr 2015, according to ClinicalTrials.gov record.
- 13 Aug 2014 New trial record